ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Book For Survivors, Other New Publications

August 23, 1991

Certification Means More Money for Nurses, ONS Finds

June 29, 1990

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010